Target intelligence / Profile preview

Niemann-Pick C1 receptor–Zaire ebolavirus glycoprotein interaction

Molecular classification
Protein-protein interaction, Virus-host receptor interaction, Other
01

Overview

The Niemann-Pick C1 receptor (NPC1)–Zaire ebolavirus glycoprotein (GP) interaction is a critical protein-protein complex that facilitates Ebola virus entry into host cells during infection. Zaire ebolavirus GP, a trimeric class I viral fusion protein on the virion surface, mediates initial attachment via its GP1 subunit and subsequent membrane fusion via GP2, with NPC1 serving as the essential endosomal receptor that binds the primed GP after cathepsin cleavage removes the glycan cap and mucin-like domain. This interaction occurs in the late endosome, where NPC1's C-terminal domain engages a hydrophobic cavity on GP1, triggering conformational changes that drive fusion loop insertion into the host membrane and viral genome release. The GP trimer forms a chalice-like structure in its prefusion state, with GP1 forming the bowl that sequesters the receptor-binding site until proteolytic priming exposes it for NPC1 engagement. This process is central to filovirus pathogenesis, enabling immune evasion through heavy glycosylation and restricting neutralizing antibody access. Targeting this interaction holds therapeutic potential for blocking Ebola entry, though no approved drugs directly inhibit it; instead, it informs antibody and small-molecule strategies against viral fusion.

Other names
EBOV GP-NPC1 interactionZaire ebolavirus GP-NPC1 complex
02

Biological functions

Viral attachmentViral entryMembrane fusionOther
03

Disease associations

Infection

Beyond the preview

Go deeper on Niemann-Pick C1 receptor–Zaire ebolavirus glycoprotein interaction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Niemann-Pick C1 receptor–Zaire ebolavirus glycoprotein interaction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call